The tetravalent DENVax vaccine contains a molecularly characterised live attenuated dengue serotype-2 virus ( DENVax-2 ) and three recombinant vaccine viruses expressing the prM and E structural genes for serotypes 1 , 3 , and 4 in the DENVax-2 genetic backbone .